Literature DB >> 12734861

High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma.

C Bassi1, G Butturini, M Falconi, M Sargenti, W Mantovani, P Pederzoli.   

Abstract

BACKGROUND: Pancreatic metastases from renal cell carcinoma are rare but highly resectable. The aim of this study was to review a series of patients with this condition.
METHODS: The study involved 22 consecutive patients with histologically proven pancreatic metastases from renal cell cancer.
RESULTS: Seventeen of the 22 patients had surgery. No patient died but eight of the 17 patients had a postoperative complication. Median follow-up was 33 (range 1-96) months. The 24- and 60-month survival probabilities were 0.84 and 0.53 respectively. Five patients who did not undergo surgery had 24- and 60-month survival probabilities of 0.53 and 0.26 respectively. The difference between the two groups was significant (P = 0.040).
CONCLUSION: Despite the slow development of these secondaries and their well encapsulated morphology, the high rate of recurrence after limited resection suggests that radical resection should be recommended. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734861     DOI: 10.1002/bjs.4072

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  42 in total

1.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Metastasis of renal cell carcinoma to the pancreas 13 years postnenhrectomv.

Authors:  Anisha Thadani; Shireen Pais; John Savino
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

3.  Unexpected Prolonged Survival After Extended and Emergent Resection of Pancreatic Metastases from Renal Cell Carcinoma.

Authors:  Stefania Brozzetti; Antonio V Sterpetti
Journal:  J Gastrointest Cancer       Date:  2019-12

4.  Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.

Authors:  Sarathi Kalra; Bradley J Atkinson; Marc Ryan Matrana; Surena F Matin; Christopher G Wood; Jose A Karam; Pheroze Tamboli; Kanishka Sircar; Priya Rao; Paul G Corn; Nizar M Tannir; Eric Jonasch
Journal:  BJU Int       Date:  2015-07-06       Impact factor: 5.588

Review 5.  Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?

Authors:  Franz Sellner
Journal:  Clin Exp Metastasis       Date:  2018-06-12       Impact factor: 5.150

6.  Metastasis to the pancreas--an indication for pancreatic resection?

Authors:  S Eidt; M Jergas; R Schmidt; M Siedek
Journal:  Langenbecks Arch Surg       Date:  2007-01-23       Impact factor: 3.445

Review 7.  Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case.

Authors:  Yasunori Deguchi; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Yoshihiro Sakamoto; Tomoo Kosuge; Nobuyoshi Hiraoka
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

8.  Pancreatic metastases: An increasing clinical entity.

Authors:  Alessandro Zerbi; Nicolò Pecorelli
Journal:  World J Gastrointest Surg       Date:  2010-08-27

9.  Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas.

Authors:  Cosimo Sperti; Valentina Beltrame; Anna Caterina Milanetto; Margherita Moro; Sergio Pedrazzoli
Journal:  World J Gastrointest Oncol       Date:  2010-06-15

10.  Pancreatic secondary lesions from renal cell carcinoma.

Authors:  Lucia Moletta; Anna Caterina Milanetto; Valter Vincenzi; Rita Alaggio; Sergio Pedrazzoli; Claudio Pasquali
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.